Usefulness of Canadian Public Health Insurance Administrative Databases  to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers

In Canada, recommendations for clinical management of hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation have been available since 2007. Eight years later, very little is known about the uptake of screening and risk-reduction measures in this population. Because Canada's public health care system falls under provincial jurisdictions, using provincial health care administrative databases appears a valuable option to assess management of BRCA1/2 mutation carriers.

Source: Canadian Association of Radiologists Journal - June 14, 2016 Category: Radiology Authors: Genevi ève Larouche, Jocelyne Chiquette, Marie Plante, Sylvie Pelletier, Jacques Simard, Michel Dorval Tags: Critically Appraised Topic / Évaluation critique Source Type: research